Blueprint Medicines Corporation (BPMC) Ownership

$89.54

north_east
$1.19 (1.35%)
Day's range
$88.63
Day's range
$91

Blueprint Medicines Corporation Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 02/07/2025 6.87 M $599.14 M   -3.51% 10.84%
VANGUARD GROUP INC 02/11/2025 6.77 M $590.91 M   1.37% 10.69%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 5.68 M $495.33 M   5.42% 8.96%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 4.28 M $373.42 M   7.99% 6.76%
STATE STREET CORP 02/14/2025 2.50 M $218.07 M   -9.60% 3.94%
FMR LLC 02/13/2025 2.25 M $196.04 M   -50.24% 3.55%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 02/10/2025 1.94 M $169.62 M   16.12% 3.07%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.49 M $130.00 M   0.67% 2.35%
MACQUARIE GROUP LTD 02/14/2025 1.26 M $109.81 M   -0.37% 1.99%
AVORO CAPITAL ADVISORS LLC 02/14/2025 1.19 M $103.36 M   100.00% 1.87%
PICTET ASSET MANAGEMENT HOLDING SA 02/12/2025 1.18 M $103.24 M   1.47% 1.87%
JPMORGAN CHASE & CO 02/12/2025 1.16 M $100.79 M   -5.44% 1.82%
ALLIANCEBERNSTEIN L.P. 02/12/2025 1.14 M $99.26 M   -6.54% 1.80%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/14/2025 1.10 M $95.67 M   42.68% 1.73%
GOLDMAN SACHS GROUP INC 02/11/2025 1.05 M $91.28 M   45.02% 1.65%
INVESCO LTD. 02/13/2025 960,437 $83.77 M   6.67% 1.52%
JANE STREET GROUP, LLC 02/14/2025 950,100 $82.87 M   68.64% 1.50%
HOOD RIVER CAPITAL MANAGEMENT LLC 02/14/2025 879,932 $76.75 M   30.86% 1.39%
EVENTIDE ASSET MANAGEMENT, LLC 02/14/2025 862,285 $75.21 M   147.28% 1.36%
AMERICAN CENTURY COMPANIES INC 02/11/2025 839,203 $73.20 M   2.96% 1.32%
ALKEON CAPITAL MANAGEMENT LLC 02/14/2025 800,628 $69.83 M   11.36% 1.26%
JANE STREET GROUP, LLC 02/14/2025 776,800 $67.75 M   -43.77% 1.23%
MILLENNIUM MANAGEMENT LLC 02/14/2025 737,364 $64.31 M   19.16% 1.16%
NORGES BANK 02/12/2025 711,164 $62.03 M   100.00% 1.12%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 02/14/2025 697,027 $60.80 M   -6.90% 1.10%
POLAR CAPITAL HOLDINGS PLC 02/14/2025 626,379 $54.63 M   -28.58% 0.99%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 604,397 $52.72 M   1.20% 0.95%
BROWN ADVISORY INC 02/14/2025 578,780 $50.48 M   -2.52% 0.91%
WOODLINE PARTNERS LP 02/14/2025 540,192 $47.12 M   19.10% 0.85%
CLEARBRIDGE INVESTMENTS, LLC 02/12/2025 490,779 $42.81 M   1.85% 0.77%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 419,190 $36.56 M   49.17% 0.66%
EMERALD ADVISERS, LLC 02/11/2025 416,866 $36.36 M   10.91% 0.66%
JANE STREET GROUP, LLC 02/14/2025 408,222 $35.61 M   115.83% 0.64%
D. E. SHAW & CO., INC. 02/14/2025 361,801 $31.56 M   41.50% 0.57%
JENNISON ASSOCIATES LLC 01/24/2025 360,208 $31.42 M   100.00% 0.57%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 350,090 $30.53 M   26.69% 0.55%
AMERIPRISE FINANCIAL INC 02/14/2025 338,115 $29.49 M   4.16% 0.53%
LORD, ABBETT & CO. LLC 02/14/2025 335,043 $29.22 M   -71.56% 0.53%
CASDIN CAPITAL, LLC 02/14/2025 326,378 $28.47 M   0.00% 0.51%
TWIN TREE MANAGEMENT, LP 02/10/2025 324,600 $28.31 M   -3.51% 0.51%
FISHER ASSET MANAGEMENT, LLC 02/05/2025 323,040 $28.18 M   -3.67% 0.51%
TD ASSET MANAGEMENT INC 02/11/2025 303,500 $26.47 M   13.88% 0.48%
BANK OF NEW YORK MELLON CORP 02/04/2025 303,432 $26.47 M   2.40% 0.48%
02/14/2025 284,654 $24.83 M   100.00% 0.45%
ENSIGN PEAK ADVISORS, INC 02/14/2025 275,424 $24.02 M   -15.55% 0.43%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 02/14/2025 275,000 $23.99 M   -5.17% 0.43%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 02/12/2025 269,990 $23.55 M   7.04% 0.43%
EMERALD MUTUAL FUND ADVISERS TRUST 02/14/2025 268,978 $23.46 M   -6.78% 0.42%
SQUAREPOINT OPS LLC 02/14/2025 265,420 $23.15 M   18.38% 0.42%
DEUTSCHE BANK AG\ 02/14/2025 261,363 $22.80 M   9.38% 0.41%

Blueprint Medicines Corporation institutional Ownership - FAQ's

During the previous two years, 434 institutional investors and hedge funds held shares of Blueprint Medicines Corporation. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 6.87 M

VANGUARD GROUP INC: 6.77 M

PRICE T ROWE ASSOCIATES INC /MD/: 5.68 M

WELLINGTON MANAGEMENT GROUP LLP: 4.28 M

STATE STREET CORP: 2.5 M

FMR LLC: 2.25 M

106.14% of Blueprint Medicines Corporation stock is owned by institutional investors.

Institutional investors have bought a total of 87.67 M shares in the last 24 months. This purchase volume represents approximately $7.85 B in transactions.